The evolution of display technologies for antibody drug discovery

Display technologies are a class of experimental methods that enable a direct association between protein function and nucleic acid sequence. Since the introduction of phage display in 1985, antibody display technologies have evolved along multiple branches and enabled new capabilities for drug discovery. Recent advances build on these foundations to accommodate new antibody modalities, improve library size, accelerate functional discovery, and leverage experimental data through computational analysis and structural predictions. Here, we discuss how recent advances in protein display are being applied to solve a broad range of problems in antibody drug discovery, immunology, and biotechnology.